Nephros IncNEPH
Price (close)
$4.14
Market cap
$45.0M
P/E
25.9x
Revenue (TTM)
$20.7M
Net income
$1.7M
Dividend yield
—
1-year total return
-1.0%
Net margin
8.4%
Revenue growth
24.2%
Debt / equity
—
What Nephros Inc does.
is a commercial-stage company that develops and markets high-performance water filtration solutions for points of use, with a core focus
on medical-grade water filtration. Our medical filtration portfolio includes two product lines: infection control and dialysis water.
The infection control segment features both microfilters (0.1 micron), which retain bacteria, and ultrafilters (0.005 micron), which
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.6M | $10.2M | $10.0M | $14.2M | $14.2M | $18.8M |
| Net income | -$4.5M | -$3.9M | -$7.4M | -$1.6M | $74,000 | $1.2M |
| Free cash flow | -$7.1M | -$1.5M | -$3.4M | $752,000 | -$547,000 | — |
More on NEPH.
- Nephros Inc summary
- Nephros Inc financial statements
- Nephros Inc key metrics
- Nephros Inc health scores and style box
- Nephros Inc earnings
- Nephros Inc dividends
- Nephros Inc valuation
- Nephros Inc ownership and insiders
- Nephros Inc peers
Figures from Nephros Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.